US Genomics, Northrop Grumman to Develop, Sell Pathogen-Detection Tool for US Gov't | GenomeWeb
NEW YORK (GenomeWeb News) — US Genomics today said it will work with aerospace and defense giant Northrop Grumman to develop and market US Genomics’ biodetection technology for the Department of Homeland Security.
 
US Genomics has already received around $23 million in funding from the Homeland Security to develop a prototype of the instrument, which uses the company’s single molecule-detection technology to find “a wide range of pathogens and toxins.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.